Timothy Sterling receives $5.7 million to study tuberculosis transmission
Timothy Sterling, MD, director of the Vanderbilt Tuberculosis Center, has received a five-year, $5.7 million grant from the National Institute of Allergy and Infectious Diseases to investigate how…
South African study site visit for the PROBe DR-TB study
Yuri van der Heijden, MD, MPH, and Charles Rhea, MPH, traveled to Johannesburg, South Africa in October 2025 to continue work on the Poor Treatment Response and Outcomes in Bedaquiline-based…
Dr. Felipe Ridolfi presents at CROI 2025 session on Pathogenesis of TB/Disease/TB Drug Exposure Relationships
Dr. Felipe Ridolfi, PhD, MD, attended the Conference on Retroviruses and Opportunistic Infections (CROI), in San Francisco, California, where he presented his poster entitled: "Isoniazid Exposure…
SUBTLE Study enrolls first participants
The Vanderbilt TB Center announced in 2024 that it had received $2.3 million in project funding from CRDF Global to conduct research on the prevalence and incidence of subclinical tuberculosis (TB…
Drs. Robert Watson and Kristin Patrick join VTC
The Vanderbilt Tuberculosis Center recently welcomed Drs. Robert "Robbie" Watson and Kristin Patrick to the research team. They join us from Texas A&M, bringing with them considerable…